ABO血型不相容肝移植的免疫抑制策略_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

 朱志军

首都医科大学附属北京友谊医院肝脏移植中心（北京 101100）;

Corresponding author：

朱志军, Email: zhu-zhijun@outlook.com

Keywords：

DOI：

10.7507/1007-9424.202104021

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 朱志军. ABO血型不相容肝移植的免疫抑制策略. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2021, 28(8): 981-986. doi: 10.7507/1007-9424.202104021 Copy

1.	Dahlgren US, Bennet W. ABO-incompatible liver transplantation - A review of the historical background and results. Int Rev Immunol, 2019, 38(3): 118-128.
2.	Starzl TE, Koep LJ, Halgrimson CG, et al. Fifteen years of clinical liver transplantation. Gastroenterology, 1979, 77(2): 375-388.
3.	Gugenheim J, Samuel D, Reynes M, et al. Liver transplantation across ABO blood group barriers. Lancet, 1990, 336(8714): 519-523.
4.	Gordon RD, Iwatsuki S, Esquivel CO, et al. Liver transplantation across ABO blood groups. Surgery, 1986, 100(2): 342-348.
5.	Nelson PW, Helling TS, Pierce GE, et al. Successful transplantation of blood group A2 kidneys into non-A recipients. Transplantation, 1988, 45(2): 316-319.
6.	Skogsberg U, Breimer ME, Friman S, et al. Adult ABO-incompatible liver transplantation, using A and B donors. Xenotransplantation, 2006, 13(2): 154-159.
7.	Kluger MD, Guarrera JV, Olsen SK, et al. Safety of blood group A2-to-O liver transplantation: an analysis of the United Network of Organ Sharing database. Transplantation, 2012, 94(5): 526-531.
8.	Farges O, Kalil AN, Samuel D, et al. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation, 1995, 59(8): 1124-1133.
9.	Reding R, Veyckemans F, de Ville de Goyet J, et al. ABO-incompatible orthotopic liver allografting in urgent indications. Surg Gynecol Obstet, 1992, 174(1): 59-64.
10.	Egawa H, Oike F, Buhler L, et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation, 2004, 77(3): 403-411.
11.	Cheng CH, Lee CF, Wang YC, et al. ABo-incompatible liver transplantation: state of art and future perspectives. Curr Pharm Des, 2020, 26(28): 3406-3417.
12.	Takahashi K, Saito K. ABO-incompatible kidney transplantation. Transplant Rev (Orlando), 2013, 27(1): 1-8.
13.	Ueda D, Yoshizawa A, Kaneshiro M, et al. Low titers of antidonor ABO antibodies after ABO-incompatible living donor liver transplantation: A long-term follow-up study. Transplant Direct, 2018, 5(1): e420.
14.	Stegall MD, Gloor JM. Deciphering antibody-mediated rejection: new insights into mechanisms and treatment. Curr Opin Organ Transplant, 2010, 15(1): 8-10.
15.	Garcia de Mattos Barbosa M, Cascalho M, Platt JL. Accommodation in ABO-incompatible organ transplants. Xenotransplantation, 2018, 25(3): e12418.
16.	Platt JL, Garcia de Mattos Barbosa M, Cascalho M. The five dimensions of B cell tolerance. Immunol Rev, 2019, 292(1): 180-193.
17.	Hsu SC, Thorat A, Jeng LB, et al. ABO-incompatible living donor liver transplantation with reduced rituximab dose: A retrospective analysis of 65 patients - Can we fast-track liver transplant surgery and improve long-term survival? Ann Transplant, 2020, 25: e923502.
18.	Bajpai M, Kakkar B, Gupta S, et al. Cascade plasmapheresis as a desensitization strategy for patients undergoing ABO incompatible living donor liver transplantation (ABOi LDLT): A single center experience. Transfus Apher Sci, 2019, 58(4): 442-446.
19.	Tanabe M, Shimazu M, Wakabayashi G, et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation, 2002, 73(12): 1959-1961.
20.	Tanabe M, Kawachi S, Obara H, et al. Current progress in ABO-incompatible liver transplantation. Eur J Clin Invest, 2010, 40(10): 943-949.
21.	Egawa H, Teramukai S, Haga H, et al. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology, 2008, 47(1): 143-152.
22.	Egawa H. Challenge to ABO blood type barrier in living donor liver transplantation. Hepatobiliary Pancreat Dis Int, 2020, 19(4): 342-348.
23.	Egawa H, Teramukai S, Haga H, et al. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study. Am J Transplant, 2014, 14(1): 102-114.
24.	Lee EC, Kim SH, Shim JR, et al. A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation. Hepatobiliary Pancreat Dis Int, 2018, 17(2): 119-125.
25.	Zhou W, Ohdan H, Asahara T. Calcineurin inhibitors block B-1 cell differentiation: the relevance to immunosuppressive treatment in ABO-incompatible transplantation. Transplant Proc, 2005, 37(4): 1808-1811.
26.	Oh J, Kim JM. Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation. Clin Mol Hepatol, 2020, 26(1): 1-6.
27.	Lee SD, Kim SH, Kong SY, et al. ABO-incompatible living donor liver transplantation without graft local infusion and splenectomy. HPB (Oxford), 2014, 16(9): 807-813.
28.	Montgomery RA, Loupy A, Segev DL. Antibody-mediated rejection: New approaches in prevention and management. Am J Transplant, 2018, 18(Suppl 3): 3-17.
29.	Cacciarelli TV, So SK, Lim J, et al. A reassessment of ABO incompatibility in pediatric liver transplantation. Transplantation, 1995, 60(7): 757-760.
30.	Honda M, Sugawara Y, Kadohisa M, et al. Long-term outcomes of ABO-incompatible pediatric living donor liver transplantation. Transplantation, 2018, 102(10): 1702-1709.
31.	Fong SW, Qaqundah BY, Taylor WF. Developmental patterns of ABO isoagglutinins in normal children correlated with the effects of age, sex, and maternal isoagglutinins. Transfusion, 1974, 14(6): 551-559.
32.	Rahfeld P, Withers SG. Toward universal donor blood: Enzymatic conversion of A and B to O type. J Biol Chem, 2020, 295(2): 325-334.
33.	Jeyakanthan M, Meloncelli PJ, Zou L, et al. ABH-glycan microarray characterizes ABO subtype antibodies: Fine specificity of immune tolerance after ABO-incompatible transplantation. Am J Transplant, 2016, 16(5): 1548-1558.
34.	Jeyakanthan M, Tao K, Zou L, et al. Chemical basis for qualitative and quantitative differences between ABO blood groups and subgroups: Implications for organ transplantation. Am J Transplant, 2015, 15(10): 2602-2615.
35.	Abegaz SB. Human ABO blood groups and their associations with different diseases. Biomed Res Int, 2021, 2021: 6629060.

1. Dahlgren US, Bennet W. ABO-incompatible liver transplantation - A review of the historical background and results. Int Rev Immunol, 2019, 38(3): 118-128.
2. Starzl TE, Koep LJ, Halgrimson CG, et al. Fifteen years of clinical liver transplantation. Gastroenterology, 1979, 77(2): 375-388.
3. Gugenheim J, Samuel D, Reynes M, et al. Liver transplantation across ABO blood group barriers. Lancet, 1990, 336(8714): 519-523.
4. Gordon RD, Iwatsuki S, Esquivel CO, et al. Liver transplantation across ABO blood groups. Surgery, 1986, 100(2): 342-348.
5. Nelson PW, Helling TS, Pierce GE, et al. Successful transplantation of blood group A2 kidneys into non-A recipients. Transplantation, 1988, 45(2): 316-319.
6. Skogsberg U, Breimer ME, Friman S, et al. Adult ABO-incompatible liver transplantation, using A and B donors. Xenotransplantation, 2006, 13(2): 154-159.
7. Kluger MD, Guarrera JV, Olsen SK, et al. Safety of blood group A2-to-O liver transplantation: an analysis of the United Network of Organ Sharing database. Transplantation, 2012, 94(5): 526-531.
8. Farges O, Kalil AN, Samuel D, et al. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation, 1995, 59(8): 1124-1133.
9. Reding R, Veyckemans F, de Ville de Goyet J, et al. ABO-incompatible orthotopic liver allografting in urgent indications. Surg Gynecol Obstet, 1992, 174(1): 59-64.
10. Egawa H, Oike F, Buhler L, et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation, 2004, 77(3): 403-411.
11. Cheng CH, Lee CF, Wang YC, et al. ABo-incompatible liver transplantation: state of art and future perspectives. Curr Pharm Des, 2020, 26(28): 3406-3417.
12. Takahashi K, Saito K. ABO-incompatible kidney transplantation. Transplant Rev (Orlando), 2013, 27(1): 1-8.
13. Ueda D, Yoshizawa A, Kaneshiro M, et al. Low titers of antidonor ABO antibodies after ABO-incompatible living donor liver transplantation: A long-term follow-up study. Transplant Direct, 2018, 5(1): e420.
14. Stegall MD, Gloor JM. Deciphering antibody-mediated rejection: new insights into mechanisms and treatment. Curr Opin Organ Transplant, 2010, 15(1): 8-10.
15. Garcia de Mattos Barbosa M, Cascalho M, Platt JL. Accommodation in ABO-incompatible organ transplants. Xenotransplantation, 2018, 25(3): e12418.
16. Platt JL, Garcia de Mattos Barbosa M, Cascalho M. The five dimensions of B cell tolerance. Immunol Rev, 2019, 292(1): 180-193.
17. Hsu SC, Thorat A, Jeng LB, et al. ABO-incompatible living donor liver transplantation with reduced rituximab dose: A retrospective analysis of 65 patients - Can we fast-track liver transplant surgery and improve long-term survival? Ann Transplant, 2020, 25: e923502.
18. Bajpai M, Kakkar B, Gupta S, et al. Cascade plasmapheresis as a desensitization strategy for patients undergoing ABO incompatible living donor liver transplantation (ABOi LDLT): A single center experience. Transfus Apher Sci, 2019, 58(4): 442-446.
19. Tanabe M, Shimazu M, Wakabayashi G, et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation, 2002, 73(12): 1959-1961.
20. Tanabe M, Kawachi S, Obara H, et al. Current progress in ABO-incompatible liver transplantation. Eur J Clin Invest, 2010, 40(10): 943-949.
21. Egawa H, Teramukai S, Haga H, et al. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology, 2008, 47(1): 143-152.
22. Egawa H. Challenge to ABO blood type barrier in living donor liver transplantation. Hepatobiliary Pancreat Dis Int, 2020, 19(4): 342-348.
23. Egawa H, Teramukai S, Haga H, et al. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study. Am J Transplant, 2014, 14(1): 102-114.
24. Lee EC, Kim SH, Shim JR, et al. A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation. Hepatobiliary Pancreat Dis Int, 2018, 17(2): 119-125.
25. Zhou W, Ohdan H, Asahara T. Calcineurin inhibitors block B-1 cell differentiation: the relevance to immunosuppressive treatment in ABO-incompatible transplantation. Transplant Proc, 2005, 37(4): 1808-1811.
26. Oh J, Kim JM. Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation. Clin Mol Hepatol, 2020, 26(1): 1-6.
27. Lee SD, Kim SH, Kong SY, et al. ABO-incompatible living donor liver transplantation without graft local infusion and splenectomy. HPB (Oxford), 2014, 16(9): 807-813.
28. Montgomery RA, Loupy A, Segev DL. Antibody-mediated rejection: New approaches in prevention and management. Am J Transplant, 2018, 18(Suppl 3): 3-17.
29. Cacciarelli TV, So SK, Lim J, et al. A reassessment of ABO incompatibility in pediatric liver transplantation. Transplantation, 1995, 60(7): 757-760.
30. Honda M, Sugawara Y, Kadohisa M, et al. Long-term outcomes of ABO-incompatible pediatric living donor liver transplantation. Transplantation, 2018, 102(10): 1702-1709.
31. Fong SW, Qaqundah BY, Taylor WF. Developmental patterns of ABO isoagglutinins in normal children correlated with the effects of age, sex, and maternal isoagglutinins. Transfusion, 1974, 14(6): 551-559.
32. Rahfeld P, Withers SG. Toward universal donor blood: Enzymatic conversion of A and B to O type. J Biol Chem, 2020, 295(2): 325-334.
33. Jeyakanthan M, Meloncelli PJ, Zou L, et al. ABH-glycan microarray characterizes ABO subtype antibodies: Fine specificity of immune tolerance after ABO-incompatible transplantation. Am J Transplant, 2016, 16(5): 1548-1558.
34. Jeyakanthan M, Tao K, Zou L, et al. Chemical basis for qualitative and quantitative differences between ABO blood groups and subgroups: Implications for organ transplantation. Am J Transplant, 2015, 15(10): 2602-2615.
35. Abegaz SB. Human ABO blood groups and their associations with different diseases. Biomed Res Int, 2021, 2021: 6629060.

Previous Article
Treatment plan and clinical effect of the first primary spontaneous pneumothorax in young patients WANGXiaolong, WEI Haitao, ZHANG Haifeng, ZHANG Feng, HU Baoli, ZHANG Donghong, DING Kai, HOU Tao, CHE Guowei
Next Article
Surgical treatment of asphyxiating thoracic dysplasia (Jeune syndrome) WANGWenlin, LONG Weiguang, CHEN Chunmei, WANG Wenjie, LIU Yang, CAI Bin, LUO Juan, CHEN Kai

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

ABO血型不相容肝移植的免疫抑制策略

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content